The Duchenne Registry
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- The Duchenne Registry
- Study ID
- NCT02069756
- Status
- Recruiting
Conditions
- Becker Muscular Dystrophy
- Duchenne Muscular Dystrophy
- Dystrophinopathy
- Dystrophinopathy Female Carrier
- Dystrophinopathy Symptomatic Female Carrier
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
The Duchenne Registry is an online, patient-report registry for individuals with Duchenne and Becker muscular dystrophy and carrier females. The purpose of the Registry is to connect Duchenne and Becker patients with actively recruiting clinical trials and research studies, and to educate patients and families about Duchenne and Becker care and research. At the same time, The Duchenne Registry is a valuable resource for clinicians and researchers in academia and industry, allowing access to de-identified datasets provided by patients and their families-information that is vital to advances in the care and treatment of Duchenne. The Duchenne Registry is a member of the TREAT-NMD Neuromuscular Network.
Key Dates
- Start date
- Oct 31, 2007
- Status verified
- May 2026
- Primary completion
- Oct 31, 2027
- Completion
- Oct 31, 2047
Study Design
- Enrollment
- 10,000 participants (estimated)
Arms
- Arm: Duchenne and Becker Muscular DystrophyPatients with Duchenne or Becker Muscular Dystrophy, as well as carrier females.
Primary Outcome Measure
Genetic variant [ Time Frame: Registrants are requested to update their medical history every 6-12 months, and they will be followed throughout their lifetime. ]
Central Contacts
- Ann Martin, MS, CGC888-520-8675
- Lauren Bogue, MS, CGC888-520-8675
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The Duchenne Registry / PPMD | Washington D.C. | District of Columbia | 20005 |
Find similar trials in Washington D.C., DC
Related Studies
- An Observational Study Comparing Delandistrogene Moxeparvovec (ELEVIDYS) With Standard of Care in Participants With Duchenne Muscular DystrophyEnrolling By Invitation · Sarepta Therapeutics, Inc. · Little Rock, Arkansas
- A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical PracticeEnrolling By Invitation · Sarepta Therapeutics, Inc. · Little Rock, Arkansas
- Duchenne Electronic Health Record StudyRecruiting · The Duchenne Registry · Little Rock, Arkansas
- Magnetic Resonance Imaging and Biomarkers for Muscular DystrophyRecruiting · University of Florida · Gainesville, Florida